Complestatin synthetic studies
Authors:
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (7) , 1697-1702
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopesNature Biotechnology, 2002
- Peptide−Small Molecule Hybrids via Orthogonal Deprotection−Chemoselective Conjugation to Cysteine-Anchored Scaffolds. A Model StudyOrganic Letters, 2002
- Macrocyclization by TTN oxidation for the synthesis of chloropeptin left-hand segmentTetrahedron Letters, 1999
- Chloropeptins, New Anti-HIV Antibiotics Inhibiting gp120-CD4 Binding from Streptomyces sp. I. Taxonomy, Fermentation, Isolation, and Physico-chemical Properties and Biological Activities.The Journal of Antibiotics, 1997
- Stereostructure of (−)-Chloropeptin I, a Novel Inhibitor of gp120−CD4 Binding, via High- Temperature Molecular Dynamics, Monte Carlo Conformational Searching, and NMR SpectroscopyJournal of the American Chemical Society, 1996
- Novel Alkaloids from the Sponge Batzella sp.: Inhibitors of HIV gp120-Human CD4 BindingThe Journal of Organic Chemistry, 1995
- The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Microbiological Reviews, 1995
- Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp.The Journal of Antibiotics, 1993
- CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle.Proceedings of the National Academy of Sciences, 1989
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986